Abstract
Key Messages•Consider safety precautions and infection control processes, particularly in remote testing locations when using rapid SARS-CoV-2 devices.•Seek oversight and partnership with an accredited clinical laboratory for guidance on setting up a quality assurance framework.•Rapid-testing for SARS-CoV-2 requires method verification prior to clinical implementation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
